Clinical Trial Update: Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 study comparing acalabrutinib to chlorambucil plus rituximab in adults with previously untreated chronic lymphocytic leukemia has results posted as of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• Chlorambucil (chlorambucil)
• Rituximab (rituximab)

Snippet

Sponsor: AstraZeneca | Conditions: Untreated Chronic Lymphocytic Leukemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-30